Cleveland Clinic Top 10 Medical Innovations for 2010

The purpose of Cleveland Clinic's annual "Top 10 Medical Innovations" is to share the perspective on what innovations would help to re-shape health care in the next year. Top 10 are representing the final results of a rigorous selection process when clinicians and researchers at the Cleveland Clinic have been asked: "What game-changing medical technology, device, or therapy do you see breaking through in 2010?"

Cleveland Clinic Top 10 for 2010

1. Bone Conduction of Sound For Single-Sided Deafness:
A new non-surgical, removable hearing and communication device designed to imperceptibly transmit sound via the teeth to help people with single-sided deafness.

2. Low-Volume, Low-Pressure Tracheal Tube Cuff To Reduce Ventilator-Associated Pneumonia:
A device that dramatically reduces the risk of ventilator-associated pneumonia and death in the hospital ICU by providing continuous effective airway seals.

3. Continuous-Flow Ventricular Assist Devices:
Tiny 3-ounce devices surgically attached alongside the heart that quietly and effectively take over the pumping ability of the heart.

4. Non-Vitamin K Antagonist Oral Anticoagulants:
Predictable and well-tolerated alternatives to the oral anticoagulant warfarin that provide a more convenient-and safe-way for patients to dose themselves and prevent blood-clot formation.

5. Fertility Preservation Through Oocyte Cryopreservation:
A rapidly-improving technology that allows eggs of a healthy woman to be safely frozen and stored, ready to be thawed and fertilized at a later date.

6. Forced Exercise To Improve Motor Function in Patient’s With Parkinson's:
Pedaling at 90 RPMs on a tandem bike to dramatically improve motor functioning of patients with Parkinson's disease.

7. Outpatient Diagnosis of Sleep-Related Breathing Disorders:
Self-contained, reliable, at-home sleep-monitoring devices for screening, diagnosing, and treatment assessment of sleep-related breathing disorders.

8. Oral Thrombopoeitin (TPO) Receptor Agonist That Stimulates Platelet Production:
A recently approved drug that stimulates production of cells in bone marrow that form platelet cells in the blood.

9. Devices for Occluding Left Atrial Appendage to Reduce Stroke Risk:
Device alternatives to long-term warfarin use that can prevent clots from developing in patients with atrial fibrillation.

10. Whole-Slide Imaging for Management of Digital Data In Pathology:
A technology for creating digital pathology slides with excellent image quality that can be viewed, stored, streamed over the Internet, and analyzed on a computer.

For further information, please visit:
http://www.clevelandclinic.org

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...